CONRAD HERBERT J 4
4 · Matinas BioPharma Holdings, Inc. · Filed May 24, 2021
Insider Transaction Report
Form 4
CONRAD HERBERT J
Director
Transactions
- Gift
Common Stock, par value $0.0001 per share
2021-01-13−50,000→ 494,622 total - Gift
Common Stock, par value $0.0001 per share
2021-01-13+50,000→ 175,000 total(indirect: By Trust) - Gift
Series B Convertible Preferred Stock
2021-01-13$1000.00/sh−100$100,000→ 0 totalExercise: $0.50From: 2018-06-21→ Common Stock (200,000 underlying) - Gift
Common Stock, par value $0.0001 per share
2021-05-20−1,145,905→ 0 total(indirect: By Trust) - Gift
Common Stock, par value $0.0001 per share
2021-05-20+1,145,905→ 1,320,905 total(indirect: By Trust) - Gift
Series B Convertible Preferred Stock
2021-01-13$1000.00/sh+100$100,000→ 100 total(indirect: By Trust)Exercise: $0.50From: 2018-06-21→ Common Stock (200,000 underlying)
Holdings
- 2,639,039(indirect: By Trust)
Common Stock, par value $0.0001 per share
Footnotes (1)
- [F1]Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.